SCHEMBL8274222

SCHEMBL8274222

CC(C)OC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ LMNA P02545 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ UCHL1 P09936 1/20 0.46
▸ KLK7 P49862 1/20 0.45
▸ RAB9A P51151 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14268224 1.00 HSD17B10 (0.56) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL895773 0.87 HSD17B10 (0.61) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL19414808 0.87 HSD17B10 (0.61) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL7286305 0.87 HSD17B10 (0.61) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL23397608 0.87 HSD17B10 (0.55) HSD17B10SMN1; SMN2NPC1LMNANPSR1
Hydrochloric Acid SCHEMBL28874591 0.87 HSD17B10 (0.52) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL18206726 0.87 HSD17B10 (0.55) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL18206724 0.87 HSD17B10 (0.55) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL28854901 0.86 POLB (0.53) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL6219879 0.86 HSD17B10 (0.59) HSD17B10SMN1; SMN2NPC1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019060860-A1 HETEROARYL COMPOUNDS AS CXCR4 INHIBITORS, COMPOSITION AND METHOD USING THE SAME Suzhou Yunxuan Yiyao Keji Youxian Gongsi (CN) 2019-03-28 — — WO disclosed
EP-1758883-B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors SCHERING CORP (US) 2011-11-02 — — EP disclosed
WO-2005116009-A1 SUBSTITUTED 2-QUINOLYL-OXAZOLES USEFUL AS PDE4 INHIBITORS SCHERING CORPORATION (US) 2005-12-08 — — WO disclosed
Send feedback